Mitigating Infectious morbidity and Growth deficits in HIV-exposed uninfected infanTs with human Milk Oligosaccharide (MIGH-T MO): a randomised trial protocol.
BMJ Open
; 12(12): e069116, 2022 12 30.
Article
in En
| MEDLINE
| ID: mdl-36585139
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pregnancy Complications, Infectious
/
HIV Infections
/
Communicable Diseases
Type of study:
Clinical_trials
/
Prognostic_studies
Aspects:
Ethics
Limits:
Child
/
Female
/
Humans
/
Infant
/
Pregnancy
Language:
En
Journal:
BMJ Open
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: